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Echinometra  lucunter  is an  abundant  sea  urchin  found  in  Brazilian  waters.  Accidents  caused  by this  animal
are  common  and  are  characterized  by  the  penetration  of the  spines  in the  skin,  which  raises  an inﬂam-
matory  reaction  through  mechanical  trauma  as  well  as  by  the presumable  action  of toxins.  Additionally,
there  have  been  reports  of  inﬂammatory  reaction  after  the  consumption  of raw  sea  urchin  eggs.  In this
work,  we  have  isolated  a peptide  from  E. lucunter  coelomic  ﬂuid  that  could  elicit inﬂammatory  reactions,
such  as  paw  edema,  leukocyte  recruitment  and  diminishment  of  the pain  threshold.  This  peptide  wasea urchin
chinometra lucunter
oelomic  ﬂuid
nﬂammation
eptide
ryptide
ast  cell
termed  Echinometrin.  Moreover,  the  peptide  administration  was  able  to  produce  in vivo  degranulation  of
mouse  mast  cells,  in  a dose–response  manner.  The  peptide  was  ‘de novo’  sequenced  by mass  spectrom-
etry  and  its synthetic  analog  could  reproduce  all the  observed  effects.  Sequence  alignment  indicates  that
this  peptide  is  comprised  in  vitellogenin,  an  abundant  nutrient  protein  present  in the  gametogenic  cells
of  sea  urchins,  making  it possible  that  echinometrin  would  be a cryptide  with  pro-inﬂammatory  effects.
©  2013 Elsevier  Inc.  All  rights  reserved.. Introduction
Echinometra lucunter (Echinodermata: Echinoidea) is an edible
ide-spread species, commonly found in tropical and subtropi-
al shallow waters, such as tide pools and reef slopes [25] in the
estern Central Atlantic, ranging from the USA throughout the
aribbean, and along most of the Brazilian shores, where it is the
ost abundant sea urchin species. It feeds on plants [34] and is
enerally found in holes in the substrate of shallow rocky areas on
eefs, particularly in locations of surf and wave surge. This species
rodes cavities or burrows in rock to create a protective chamber
1]. The pharmacological (pro-inﬂammatory) and initial biochemi-
al features of the spines extracts of this species have already been
valuated by our group [45,46], once this urchin is responsible for
he majority of the sea animal accidents reported in the Brazilian
oastal medical facilities [22].
∗ Corresponding  author at: Avenida Vital Brazil, 1500, CEP: 05503-900, São Paulo,
P, Brazil. Tel.: +55 11 2627 3793.
E-mail  address: jmsciani@butantan.gov.br (J.M. Sciani).
196-9781/$ – see front matter © 2013 Elsevier Inc. All rights reserved.
ttp://dx.doi.org/10.1016/j.peptides.2013.07.031Sea urchins have a large quantity of perivisceral coelomic ﬂuid
by which the internal organs seem to be protected [19]. The survival
of echinoderms in the microorganism-rich marine environment is
dependent on their ability to defend themselves against microbial
invasion [21]. These animals are directly exposed to potentially
pathogenic microorganisms and have developed defense responses
mainly based on immunocytes and humoral factors contained in
the coelomic ﬂuid [4]. This ﬂuid contains cells, capable of mov-
ing and internalizing inert or live particles. There are ﬁve types of
coelomocytes in sea urchins, classiﬁed as amoebocytes, hemocytes,
spherical cells, progenitor cells and crystal cells [17].
Amoebocytes and spherulocytes comprise the main coelomo-
cyte population, responsible for a wide repertory of immunological
functions, as cellular recognition, phagocytosis, cytotoxicity,
antibacterial activity and inﬂammatory reactions [4]. However, few
molecules bearing immunological functions have been described
and isolated from sea urchins.Sea  urchins roes are considered to be culinary delicacies in many
parts of the world, such as in Europe, Japan, the United States,
Canada and Brazil, and are often consumed raw, which increases
the chance of an accident/envenomation. In Brazil there have been
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eports of gastrointestinal inﬂammatory reactions after the con-
umption of such food [12,16].
Inﬂammation is a process to repair injured tissues, character-
zed by cellular, vascular and biochemical alterations. The process
s divided into two phases: acute and chronic, differentiated by the
ype of cells and inﬂammatory mediators released [30]. When there
s an injury, cells are activated and the mediators are released. One
f these cells is mast cells [20].
Mast cells are located in a variety of tissues, such as intestinal
nd pulmonary epithelium, connective tissue and skin, associated
ith blood and lymphatic vessels and nerves [31]. They are key
layers on the inﬂammatory processes because is the ﬁrst cells
o initialize the inﬂammation [15,40]. When these cells are acti-
ated, granules containing stored inﬂammatory mediators (such
s vasoactive amines and neutral proteases) are exposed, a process
nown as mast cell degranulation. The activation is mediated by IgE
nd complement proteins [26]. However, it was described some
olecules that are able to induce the degranulation, for instance
8/80, a polymer amine [27] and peptides, such as mastoparans,
solated from wasp venom [24]. Such molecules would serve as
mportant biotechnology tools in the study of mechanism of action
n allergy, inﬂammation, and even as an adjuvant vaccine [33].
In  this work we report the isolation, biochemical characteriza-
ion and pharmacological properties of a novel octapeptide from
he coelomic ﬂuid of E. lucunter sea urchin, able to induce mast cell
egranulation and evoke inﬂammatory effects. This peptide was
ermed echinometrin.
.  Materials and methods
.1.  Drugs and reagents
All  the employed reagents were of analytical grade and were
urchased from Sigma Co. (St. Louis, MO,  USA), unless otherwise
tated.
.2. Animals
Male Swiss mice (20–25 g) and male Wistar rats (180 g) were
sed throughout the study. All animals were treated and main-
ained under ethical conditions, at animal housing facilities of
nstituto Butantan, approved by the Institutional Animal Care Com-
ittee of the Butantan Institute (CEUAIB, protocol number 438/07).
.3. Sea urchins and coelomic ﬂuid collection and sample
reparation
Specimens of E. lucunter were collected in São Sebastião, SP,
razil (23◦49′53′′S; 45◦31′18′′W),  under license number (13852-
) from the Brazilian Environmental Agency (IBAMA—Instituto
rasileiro do Meio Ambiente e dos Recursos Naturais Renováveis).
nimals were collected without distinction of sex, age or size. The
oelomic ﬂuid was extracted from the sea urchin by puncturing
he peristomial membrane, being approximately 30 mL  by animal.
ight after collection, the ﬂuid was added to acetic acid 0.05% (v:v;
nal concentration) or protease inhibitor cocktail (Roche Applied
cience, Complete, Cat No. 04 693 124 001), to prevent protein
nd peptide hydrolysis, and was kept in ice bath until further
rocessing. The coelomic ﬂuid was then centrifuged at 1248 × g
or 5 min, at 4 ◦C and the supernatant was processed by solid
hase extraction (SPE) using C18 cartridges (Strata®, 55 m,  70 A˚,
 g/20 mL,  Phenomenex Inc., Torrance, CA, USA) and elution with
5% acetonitrile (ACN), containing 0.1% triﬂuoroacetic acid (TFA).s 53 (2014) 13–21
2.4. Chromatographic steps
The 25% ACN SPE-fraction was puriﬁed by reversed phase high
performance liquid chromatography (RP-HPLC) using a binary
HPLC system (20A Prominence, Shimadzu Co., Japan). Aliquots of
the samples were loaded in a C18 column (ACE C18, 5 m,  100 A˚,
250 mm × 7.75 mm)  in a two-solvent system: (A) TFA/H2O (1:1000)
and (B) TFA/Methanol/H2O (1:900:100). The content was  eluted at
a constant ﬂow rate of 1.7 mL  min−1 with a 0–100% gradient of sol-
vent B over 35 min, after a 5 min  isocratic elution with 0% B. The
HPLC column eluates were monitored by a Shimadzu SPD-M20A
PDA detector scanning from 200 to 500 nm (1 nm steps) and the
peak of interest was  manually collected.
For sample puriﬁcation, one additional chromatographic step
was necessary, employing a C18 core–shell column (2.6 m,  100 A˚,
100 mm × 4.6 mm,  Kinetex®, Phenomenex Inc., USA), at a constant
ﬂow rate of 1.2 mL  min−1 with a 0–100% gradient of solvent B
(TFA/ACN/H2O; 1:900:100) over 20 min, after a 5 min  isocratic elu-
tion with 0% B.
2.5. Mass spectrometry
Mass  spectrometry analyses were performed in an ESI-IT-
Tof mass spectrometer (Shimadzu Co., Japan). The sample was
diluted in a 50% ACN containing 0.5% formic acid, and was  directly
introduced in the spectrometer using a Rheodyne 7010 sample
loop, at a ﬂow rate of 50 L min−1, in positive ionization mode. The
interface voltage was  kept at 4.5 kV, the detector voltage at 1.76 kV
and the capillary temperature at 200 ◦C. The instrument control
and data acquisition was  conducted by LCSolutions (Shimadzu Co.,
Japan), being the mass spectra collected in the 50–2000 m/z range.
For the MS/MS  analysis, argon collision energy was  kept in 50%
and the precursor ions were selected under a 0.5 m/z window.
The results were automatically processed by Peaks 5.0 software
(Bioinformatics Solution Inc.), and then manually veriﬁed. The
Ile/Leu alternates were solved by amino acid analyses. Brieﬂy, the
sample was hydrolyzed with 1 M HCl (containing phenol) in a
sealed ampoule, at 110 ◦C for 10 h. It was then dried and washed
with H2O:ethanol:triethylamine (TEA) (2:2:1) prior to phenylthio-
hydantoin (PTH) derivatization (15 min) in ethanol:TEA:PTH:H2O
(7:1:1:1). The reaction products were then analyzed by HPLC and
compared to an 18 amino acid standard.
2.6. Peptide synthesis
Synthetic  peptide was  obtained in automated bench-top simul-
taneous multiple solid-phase synthesizer (PSSM 8 system from
Shimadzu Co., Japan) using solid phase peptides synthesis by the
Fmoc-Procedure [5]. The peptide was puriﬁed by reversed-phase
chromatography (Shim-pack Prep-ODS, 5 m,  20 mm × 250 mm
Shimadzu Co.) semi-preparative HPLC, and the purity and identity
of the peptide was conﬁrmed by ESI-IT-TOF mass spectrometry and
by analytical HPLC, in the same conditions described above.
2.7.  Intravital microscopy of cremaster venules
Leukocyte responses within mouse cremaster venules were
assessed by intravital microscopy. Echinometrin (0.5 g/g animal,
diluted in 100 L of sterile saline) or sterile saline (control) were
injected in mice (n = 5), into the subcutaneous (s.c.) tissue of the
scrotal bag. After 2 or 24 h, animals were anesthetized with injec-
tion (s.c.) of ketamine (100 mg/kg) and xylazine (10 mg/kg) and the
cremaster muscle was  exteriorized for microscopic examination
in situ as previously described by Baez [6]. During the experimental
procedure, mice were maintained on a special board thermostat-
ically controlled at 37 ◦C, which included a transparent platform
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n which the cremaster was placed. Leukocyte responses were
valuated by light microscope (Axioplan II, Carl Zeiss, Germany),
quipped with Achroplan objectives 10.0/0.25 (longitudinal dis-
ance/numeric aperture and 1.60 optovar). Images were captured
y a video camera (JVC, Japan) and simultaneously transmitted to a
V monitor. Images were digitalized in the computer and analyzed
y software (KS 300, Kontron, Carl Zeiss, Germany). One to three
ost-capillary venules were selected at random. After the stabiliza-
ion period (initial 10 min), rolling and adhering leukocytes were
ounted during 3 min  in a 100-mm vascular segment. Firmly adher-
nt leukocytes were considered those cells remaining stationary
or at least 30 s within a given 100-mm vessel segment. Trans-
igrated leukocytes were quantiﬁed as those in the extravascular
issue within 50 mm of each side of the 100-mm vessel segments
tudied.
.8. Evaluation of paw edema
Paw edema was induced by intraplantar injection of 10 or
0 g/paw of the peptide, diluted in 30 L of sterile saline (n = 5).
he contra lateral paw received the same volume of sterile saline
control paw). Paw edema was evaluated by a plethysmometer
Letica, Spain) at 0, 5, 15, 20, 30, 40 and 50 min  after injection.
esults were expressed as the difference (%) of volume between
aws injected with sample and sterile saline, and compared to the
esults before the administration.
.9.  Nociceptive threshold evaluation
Rats (n = 8) were evaluated by the paw pressure test before and
t different times (1, 2 and 4 h) after intraplantar injection of echi-
ometrin (10 g/paw). The pain threshold was measured using an
go Basile® pressure apparatus, essentially as described elsewhere
41]. Brieﬂy, a force of increasing magnitude (16 g/s) was  applied
o the paw. When the rat reacted by withdrawing the paw, the
orce (in g) required to induce this response represented the pain
hreshold. The hyperalgesic activity was expressed as the decrease
n the force needed to induce the withdrawal response in treated
ats compared with control rats that received only sterile saline.
.10.  Histological assessment of mesenteric mast cell (MC)
egranulation
Echinometrin, dissolved in 500 L sterile physiological saline
0.05, 0.5 and 1 g/g animal) was injected by the intraperitoneal
ip.) route. Control animals received 500 L of sterile saline. At
elected time intervals (10–60 min) after these injections, the
nimals were euthanized under halothane atmosphere and exsan-
uinated. The abdomen was opened and the mesentery was
arefully removed for histological assessment of mast cell degra-
ulation. Mesentery was  placed in a 4% formaldehyde solution at
◦C for 2 h, mounted on a glass slide and then stained with Giemsa.
ast cell degranulation was expressed as percentage of mast cells
ith extruded granules relative to the total mast cells present in the
tained mesentery. At least 100 cells were counted per stained tis-
ue. In rats, degranulated cells can be visualized once the granules
emain stained even after discharge from cells [38].
.11. Hemolytic assay
The  hemolytic assay was performed following the method
escribed by Al-Badri et al. [2], with some modiﬁcations. Fresh
uman blood was obtained from healthy donors and erythrocytes
ere separated by centrifuging whole blood (3000 rpm, 10 min), to
emove plasma and white cells. One mL  of red blood cells (RBC)
ere diluted with 9 mL  of PBS buffer (10 mM phosphate buffer, pHs 53 (2014) 13–21 15
7 and 150 mM NaCl). The suspension was further diluted to give
a RBC 4%. The sample, diluted in the assay buffer, was incubated
with RBS 4% (20 L) and PBS buffer (50 L) at 37 ◦C for 1 h. The
tube was centrifuged at 1240 × g for 5 min  and 60 L of supernatant
were transferred to 96-well plate, and the hemoglobin released was
measured at 414 nm.  Data were compared with negative control
(100 L PBS buffer and 20 L RBC 4%) and a positive control (50 L
PBS buffer, 50 L Triton X-100 0.1% and 20 L RBC 4%). Experiments
were performed in triplicate. Percent hemolysis was  calculated as
follows: (%) = (Asample − Abuffer)/(Atriton − Abuffer) × 100.
2.12.  Antimicrobial assay
Antimicrobial  activity was monitored by a liquid growth inhibi-
tion assay against Micrococcus luteus A270, Escherichia coli SBS 363,
Pseudomonas aeruginosa ATCC 14502 and Staphylococcus aureus
ATCC 6538, as described by Bulet et al. [9]. Pre inocula of the strains
were prepared in Poor Broth (PB) and incubated at 37 ◦C with shak-
ing. The absorbance at 595 nm was determined and one aliquot
of this solution was taken to obtain cells in logarithmic growth
(A595 nm ∼0.6), and diluted 600 times (A595 nm = 0.0001). The
fractions and pure peptides were dissolved in sterile Milli-Q water,
at a ﬁnal volume of 100 L (10 L of the peptide and 90 L of the
inoculum in PB broth). After incubation for 18 h at 30 ◦C the inhibi-
tion of bacterial growth was determined by measuring absorbance
at 595 nm.
2.13.  Statistical and sequence analyses
Results are presented as mean ± standard error of mean. Statis-
tical evaluation of data was  carried out by Student’s t test, one-way
ANOVA followed by Tukey’s post-test or repeated measures two-
way ANOVA followed by Bonferroni post-test (GraphPad Prism 5,
GraphPad Software Inc, USA). Differences of results were consid-
ered statistically signiﬁcant when p < 0.05.
Peptide sequence analyses was  performed by using the NCBI
BLAST server, BLASTP 2.2.28 Program and the nr database (All non-
redundant GenBank CDS translations + PDB + SwissProt + PIR + PRF
excluding environmental samples from WGS  projects) restricting
or not the organisms to sea urchins (taxid:7625), according to [3]
for blastp and according to [3,8,44] in the case of DELTA-BLAST.
Multiple sequence alignment was performed by ClustalW2, with
default parameters [29].
3.  Results
3.1. Puriﬁcation and biochemical characterization
The 25% ACN SPE fraction was  analyzed RP-HPLC (Fig. 1A) and
peaks were manually collected and tested for MC  degranulation
and pro-inﬂammatory effects, being one peak positive in the assays
(arrow). Since more than one molecule were found in the peak
of interest (data not shown), one additional chromatographic step
was necessary to purify the molecule. Biological assay monitoring
indicated that the active molecule was present in the peak indicated
by the arrow, in Fig. 1B. Each 30 mL of coelomic ﬂuid processed,
about 400 g of the interested peptide was  obtained.
Mass  spectrometry analyses of the active peak indicated the
presence of a possible peptide (Fig. 2; m/z = 529.2924 [M+2H]2+;
m/z = 353.1980 [M+3H]3+ and m/z = 265.1490 [M+4H]4+), with
molecular mass of 1056.591 ± 0.006 Da. The [M+2H]2+ ion was  CIF
dissociated in the mass spectrometry (Fig. 3A) and the daugh-
ter ions allowed the de novo sequence of a peptide. Spectra were
analyzed by PEAKS (Demo version) and manually checked for accu-
racy and precision. The deduced sequence of the peptide was
LRKLMLQR. The presence of leucine instead of isoleucine could
16 J.M. Sciani et al. / Peptides 53 (2014) 13–21
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Dig. 1. Chromatographic separation of echinometrin by RP-HPLC, using a C18 col
ractionated coelomic ﬂuid of E. lucunter; (B) re-chromatography of the 26′ fraction
e conﬁrmed by amino acid analysis (supplemental material). The
eptide was termed echinometrin, in allusion to the animal genus.
A synthetic echinometrin analog was obtained by solid phase
eptide synthesis and analyzed by mass spectrometry (MS  and
S/MS), in order to conﬁrm the homology with the natural pep-
ide. Fig. 3B presents the dissociation of the [M+2H]2+ ion of the
ynthetic peptide. It is possible to note the spectra are virtually
dentical in the fragmentation pattern, in the measured mass of the
ons and in the relative intensity of the peaks.
The amino acid sequence of echinometrin was submitted to
ELTA-BLAST analyses [3,8,44] against the nr database. The forthas described in Section 2. (A) HPLC proﬁle generated by the injection of SPE pre-
ining the peptide. Arrows indicate the active fraction (echinometrin).
blast hit, out of the 100 best protein hits, was  a continuous region
from a predicted uncharacterized protein from Strongylocentrotus
purpuratus sea urchin [LOC583660 Strongylocentrotus purpuratus
Sequence ID: ref|XP 003726745.1|], . . .EG367LRKLMLER374FM. . .,
with a conservative Glu/Gln substitution at the 7th amino acid
(echinometrin numbering). Also, presenting a lower score, there
was a blast hit with ﬂagellar creatine kinase (P18294) of S. pur-
726 733puratus (. . .QI LRALRLQK RG. . .). The aligned sequences are
presented in Table 1, which also contains the corresponding region
of the only vitellogenin with 3D structure, isolated from the silver
lamprey. The full alignment of the two viltellogenins is presented
J.M. Sciani et al. / Peptides 53 (2014) 13–21 17
Fig. 2. Mass spectrometry proﬁle of puriﬁed echinometrin. The charge states of the peptide are annotated. Insert: zoomed isotopic distribution of the [M+3H+] ion.
Fig. 3. MS2 proﬁles of the CID dissociated native (A) and synthetic (B) peptides. The mass spectrum in B is annotated according to the theoretical mass table.
Table 1
CLUSTAL 2.1 multiple sequence alignment.
Echinometrin  --- --- --- --- ---- LRKLM LQR--- --- ---------- - 8
H3I5S1(1015-1055) MGF SLN PLE VGFKVEGLRKLM LERF-MSNS ESGDGDNRDR L 40
P18294(710-745) VKL PLL SKY PRF D -QILRALR LQKRGT GGV DTASTDGTFD I 40
Q91062(666-706) MGY ASD IVE FGL RAEG LQELL YRGS-QEQD AYGTALDRQT L 40
Consensus                *: *   . 
18 J.M. Sciani et al. / Peptides 53 (2014) 13–21
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Fig. 4. Inﬂammatory effects of echinometrin. (A) Cell count in the cremaster muscle microcirculation after 2 and 24 h of echinometrin administration; (B) pain threshold
evaluation after peptide injection; (C) paw edema percentage (control-related) after 10 and 20 g natural peptide; (D) edema-formation evaluation after 10 g synthetic
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n the supplemental material, which also contains the 3D structure
f the lamprey vitellogenin, showing (in red) the region that con-
ains the echinometrin related peptide. Noteworthy, this region is
xposed and accessible to proteolysis.
.2. Pro-inﬂammatory effects
Echinometrin was able to induce alterations in the mouse micro-
irculation, with recruitment of leukocytes in the area of peptide
njection, the cremaster muscle. After 2 h of injection, a dimin-
shment of rolling cells and an increase of adhered and migrated
ells could be observed (Fig. 4A). After 24 h, rolling and adhesion
ells returned to the basal levels, although migrated cells were still
resent (Fig. 4A).
In  order to evaluate the hypernociceptive effects, rats were sub-
itted to paw pressure test. Initially, all animals presented the
ame pain threshold. One hour after 10 g/paw of echinometrin
njection, the pain threshold signiﬁcantly diminished, in compari-
on to the control group (Fig. 4B). After 2, the diminishment of the
ain threshold was still presented and only 4 h after echinometrin
dministration, the pain threshold value returned to the initial val-
es.
Echinometrin also induced a dose-dependent paw edema,
hich reaches values of 64% with 20 g/paw and 42% with
0 g/paw (Fig. 4C). The maximum edema value was  obtained
5 min  after injection, and was decreasing slowly.
The  synthetic peptide was also assayed in mouse paw edema
est, in the same concentration as the natural peptide (10 g), as
erformed before. The synthetic peptide reproduced the effects
bserved by natural peptide in this model of inﬂammation, as
hown in Fig. 4D.3.3. Mast cell degranulation
As  depicted in Fig. 5A, echinometrin (0.5 g/g mouse) was able
to induce the MC  degranulation after 30 min  of administration.
Spread granules around the MC  were observed by light microscopy,
being considered degranulated. The degranulation started 10 min
after the peptide injection and progressively increased, until 30 min
(Fig. 5B). In 60 min  after injection, no degranulated cells were
observed. This effect occurred in a concentration–response manner,
as showed in Fig. 5C, in 30 min  after injection.
3.4.  Hemolysis/antibacterial effect
Echinometrin was  not able to induce hemolysis in human eryth-
rocytes. Moreover, the peptide was  not antibacterial, once did not
cause lysis of bacteria, for the four tested strains (data not shown).
4. Discussion
In this work we report the isolation and biochemical charac-
terization of echinometrin, a peptide/cryptide isolated from the
peristomial coelomic ﬂuid of E. lucunter sea urchin, which was able
to initiate an inﬂammatory response in mammals, due to (at least
in part) its capacity to degranulate mast cells (MCs).
MCs  are known to be essential for the resolution of bacterial
infections through neutrophil mobilization to the site of infection.
These cells seem to coordinately initiate innate immune response
(immune cell migration), believed to be essential in stimulating
the adaptive immune response. These functions are believed to
be due to the capacity of MCs  to rapidly release prestored inﬂam-
matory mediators within few minutes after activation [33], what
contribute to rapid effects. Moreover, MCs  are present in tissues
J.M. Sciani et al. / Peptides 53 (2014) 13–21 19
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hat are in the ﬁrst contact with the antigen (e.g. connective tissue)
eing the ﬁrst cells to act when the tissue is injured [28].
The  rapid effect observed after echinometrin injection is prob-
bly due to the participation of MCs: the studied tissue was
esentery (the ﬁrst contact with the toxin, injected by intraperi-
oneal route) and the pre-stored mediators in MCs  contribute to
 rapid effect. Considering the inﬂammation as a multi-mediated
rocess, the activation of MCs  can release other mediators that
rolong the inﬂammation, once we observed a decrease of pain
hreshold 2 h after echinometrin injection.
MC  degranulation (MCD) may  occur either by the activation
f G protein, or through mast cell membrane lysis or even by
oth processes simultaneously [49]. When activated, MC  releaseel, control; right panel degranulation (arrows) observed after echinometrin injec-
granulation effect, observed after echinometrin administration; (C) echinometrin
histamine  and other inﬂammatory mediators, including proteases
such as tryptase and chymase, lipid mediators (prostaglandins and
leukotrienes) and cytokins [36]. These cells exhibit many active
molecules on their surface that enable the cells to react to both
IgE and non-IgE-related stimuli and to release mediators, result-
ing in an attraction of inﬂammatory cells. The high afﬁnity of MCD
peptide for mast cells makes it a suitable substance for studying
allergic and inﬂammatory processes [10,40].
Peptides causing degranulation of MC  have already been
described in bee and wasp venoms [7,23,35,36,48]. Depending
on the doses, they can cause both inﬂammatory and anti-
inﬂammatory activity [10]. Moreover, these peptides are thought to
be  involved in allergic and inﬂammatory processes related to type
2 eptide
I
t
m
p
e
h
o
e
m
b
p
e
h
a
a
a
t
p
p
a
a
c
r
s
ﬁ
I
f
o
e
a
f
a
n
t
g
o
g
(
d
m
a
T
a
a
s
w
s
t
t
p
g
t
p
s
u
i
s
e
d
r
t0 J.M. Sciani et al. / P
 hypersensitivity reaction that is caused by mast cell degranula-
ion and subsequent release of histamine and other inﬂammatory
ediators [23]. The mechanism of action is the interaction of the
eptide with G-protein coupled receptors (GPCR), activating differ-
nt types of basophils and chemotaxis of leukocytes. On the other
and, some peptides present -helical conformations depending
n the environment, being an amphipathic structure, which favors
lectrostatic interactions with the negatively charged biological
embranes, which may  lead to peptide insertion into the mem-
rane bilayer and consequent lysis of the cell [7,36]. Thus, these
eptides are hemolytic and/or antimicrobian [35,48].
In  the case of echinometrin, the suggested mechanism is the
ntry in the MCs  and activation of G protein, once this peptide
as no effect on lysis of membranes (it is not hemolytic and
ntimicrobial) [11]. The observed pro-inﬂammatory effects, such
s leukocyte recruitment, paw edema and hypernociception, prob-
bly occurred due to the release of mediators from MCs. During
he inﬂammation process, the cell recruitment is caused by the
resence of chemotactic mediators, such as histamine, bradykinin,
rostaglandin, etc. The action of mediators induce hemostatic alter-
tions (causing edema) and leukocyte migration, by expression of
dhesion molecules on leukocytes (selectins and integrins), that
ause leukocyte–endothelium interaction [18,37].
Yamasaki et al. [51] identiﬁed a 152 kDa allergen from sea urchin
oes – the major yolk protein (MYP) – that was able to increase the
erum concentration of IgE. Moreover, Rodriguez et al. [43] identi-
ed a 118 kDa protein from the urchin roes that mediated allergy by
gE, as well. Echinometrin, on the other hand, possess a clearly dif-
erent mechanism of action that includes no Ig involvement, once
ne single peptide dose was enough to raise the pharmacological
ffects, whereas the raising of IgE levels require at least two  antigen
dministrations [32].
MYP  is abundant in sea urchin coelomic ﬂuid, and is also a
ragment of vitellogenin, another abundant protein in both male
nd female sea urchin individuals. Vitellogenin is incorporated into
utritive phagocytes, as a temporary stock, and is transported to
he oocytes, to be accumulated as MYP, as a source of nutrients to
ametogenesis [13,50].
BLAST  analyses of echinometrin indicates it posses high homol-
gy with an internal sequence of the S. purpuratus uncharacterized
ene product of LOC583660, with only a Gln/Glu substitution
Table 1). Annotations on this entry reports a von Willebrand type D
omain (VWD) besides a domain of unknown function (DUF). Data
ining on these data showed that LOC583660 is also deposited in
n alternate assembly of S. purpuratus genome as NW 001467127.
his entry, however, is differently annotated, marking this protein
s “similar to vitellogenin fused with superoxide dismutase” and
lso “similar to Sperm-activating peptides precursor”. Finally, this
equence is also present in UNIPROT, under accession H3I5S1, in
hich it seems to have compiled all these annotations and con-
olidated them under a single entry. The similarities annotated in
his entry are being similar to VWD  and to DUF, but also to lipid
ransport activity and vitellogenin.
According to our interpretation, echinometrin would be a
roteolytically generated internal fragment of E. lucunter vitello-
enin (being the Glu/Gln substitution a species characteristic);
herefore, it would be a cryptide. Brieﬂy, cryptides are bioactive
eptides generated by the proteolyses of non-classical precur-
or proteins that displays a biological function that normally is
nrelated to the original protein function [39]. Our hypothesis
s that the E. lucunter sea urchin vitellogenin, a nutrient protein
ource, would be enzymatically cleaved releasing – among oth-
rs – echinometrin, a peptide able to degranulate mast cells and
evelop an inﬂammatory reaction. These rather different biological
oles (nourishment × degranulation) would characterize the cryp-
ic function of echinometrin. Considering that the vitellogenin iss 53 (2014) 13–21
in contact with the sea urchin eggs, and echinometrin, a peptide
secreted to the coelomic ﬂuid, is also in contact with the eggs,
this could be a possible explanation for the reported allergenic
responses after the raw consumption of this animal.
Moreover, according to the deduced sequence of the possible
precursor (H3I5S1), the release of echinometrin does not follow
classical proteolytic processing sites, and would thus require two
or more enzymes for the peptide processing. On the other hand,
echinometrin may  also be a creatine kinase derived cryptide. Our
blast analyses point out this possibility, at a lower score position.
However, one must take into account that sequences are being com-
pared to S. purpuratus genome, due to the lack of information on
E. lucunter genome/proteome. This piece of information is note-
worthy to mention, due to the fact that our group has previously
identiﬁed another marine animal vasoactive cryptide derived from
creatine kinase, orpotrin [14]. In that occasion we have postulated
that, besides trypsin-like serine peptidases, a cysteine peptidase,
cathepsin L, would be able to cleave (according to the known subsite
speciﬁcity [Merops – the peptidase database; 42]), creatine kinase
and release orpotrin. In our investigations on E. lucunter biochem-
ical and pharmacological features, we  have describe a Cathepsin
B/X like activity [45] that, perhaps, could be responsible for creatine
kinase degradation with consequent release of echinometrin, mak-
ing creatine kinase a multifunctional protein, similar to Lactoferrin
[47]. Cathepsin B can cleave after glycine and Arginine residues
and a glycine residue precedes echinometrin and arginine is the
last amino acid of the peptide, when one considers creatine kinase
amino acid sequence.
In  conclusion, taking into account that major yolk protein has
already been described as an anaphylactic reaction agent [51], and
that is passive of being cleaved by cathepsin B [52], an enzyme
previously described for E. lucunter, we  describe in this work echi-
nometrin, a cryptide derived from a putative vitellogenin that is
able to cause inﬂammation probably by mast cell degranulation.
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